Desmond Schatz, M.D.
Interim Chair, UF College of Medicine Department of Pediatrics;
Interim Physician-in-chief, UF Health Shands Children’s Hospital;
Medical Director of the Diabetes Center and Associate Director of the GCRC at the University of Florida, Gainesville
Biomedical Sciences Building – J598
Up to 3 million Americans are stricken with type 1 diabetes, but the epidemic spans the globe and is rapidly worsening. The frequency of the disease has already soared five-fold in the past 50 years alone, and the costs to human health come into sharp focus. Diabetes is one of six leading causes of death in the United States, and the No. 1 cause of acquired blindness, kidney failure and non-traumatic amputation. It also fuels cardiovascular disease, the nation’s No. 1 killer, and accounts for more than $174 billion in health-care expenditures, with type 1 diabetes accounting for a disproportionate share of those costs. Dr Schatz’ research has focused on the prediction, natural history, genetics, immunopathogenesis and prevention of Type 1 diabetes, as well as the management of children and adolescents with Type 1 diabetes.
Dr Schatz is Professor and Associate Chairman of Pediatrics, Medical Director of the Diabetes Center and Associate Director of the GCRC at the University of Florida, Gainesville. He is a physician-scientist and is the Principal Investigator (PI) on multiple funded peer reviewed grants from the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation (JDRF). He is currently PI of the University of Florida Clinical Center participating in the NIH-funded international network (TrialNet) aimed at preventing Type 1 diabetes. He is also PI on JDRF funded studies aimed at reversing Type1 diabetes using autologous stem cells (cord blood) and serves as co-PI on a Program Project Grant examining the immunopathogenesis of Type 1 diabetes. He is co-PI for NIH-funded newborn genetic screening (PANDA) studies in North Central Florida as well as the international TEDDY consortium aimed at identifying triggers of the disease. He has served in numerous capacities for the American Diabetes Association, on the Lawson Wilkins Pediatric Endocrine Society and on study review panels for the NIH and JDRF. He also serves on the external advisory board for the NIH- and CDC-funded SEARCH study and the TODAY study in youth with type 2 diabetes and on the JDRF-funded Australian INIT II studies.
Additional publications can be found in PubMed.
Dr Schatz has published over 360 manuscripts and book chapters, the majority pertaining to the prediction, natural history, genetics, immunopathogenesis and prevention of the disease, as well as the management of children and adolescents with Type 1 diabetes.